|
|
||||||||||||||
|
|
|||||||||||||||
COMMENTARY |
| Near misses and research subjects |
Division of General Internal Medicine and Public Health, Vanderbilt University Medical Center and the Department of Veterans Affairs, Tennessee Valley Healthcare System, GRECC, Nashville, TN, USA
Correspondence to:
Dr H J Murff
Department of Veterans Affairs, VA Tennessee Valley Healthcare System, GRECC, 1310 24th Avenue South, Nashville, TN 37212-5381, USA; Harvey.murff@med.va.gov
Keywords: patient safety; clinical research; near misses
| The first 150 words of the full text of this article appear below. |
As in clinical care, the highest priority of clinical research is to protect participants from any undue harm. There are inherent risks involved in any human experiment, but careful analysis of several research related fatalities has clearly shown that human error and system failures contributed to these events.1,2 While clinical medicine has embraced organizational based approaches to patient safety, much of the clinical research safety process remains narrowly focused. This focus has resulted from the traditional "protocol-centric" approach for managing clinical research risk. Both Institutional Review Boards and Data Safety Monitoring Boards predominately review safety problems on a study by study basis. While these traditional approaches have been remarkably successful, their narrow scope may limit their ability to identify and manage clinical research risks comprehensibly.
Clinical research and clinical care share many similar risks. Both involve analogous procedures, many of which are invasive, and both
Relevant Article
Qual. Saf. Health Care 2006 15: 225.
This article has been cited by other articles:
![]() |
M M Walton Hierarchies: the Berlin Wall of patient safety. Qual. Saf. Health Care, August 1, 2006; 15(4): 229 - 230. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |